|
|
Volumn 578, Issue 7795, 2020, Pages 347-348
|
|
More than 80 clinical trials launch to test coronavirus treatments
a
a
NONE
|
|
Author keywords
Diseases; Drug discovery; Infection; Virology
|
|
Indexed keywords
5,8-DIVINYL-1,4-DIHYDRO-1,4-DI-O-BETA-D-GLUCOPYRANOSYL-2,3-DIOXANE;
ADENOSINE PHOSPHATE;
ALANINE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
CHLOROQUINE;
DIOXANE DERIVATIVE;
LOPINAVIR;
LOPINAVIR-RITONAVIR DRUG COMBINATION;
MONOSACCHARIDE;
REMDESIVIR;
RITONAVIR;
STEROID;
ANIMAL;
BETACORONAVIRUS;
CHINA;
CHINESE MEDICINE;
CLINICAL TRIAL (TOPIC);
CORONAVIRUS INFECTION;
DISEASE MODEL;
DRUG COMBINATION;
DRUG EFFECT;
HUMAN;
ORGANIZATION AND MANAGEMENT;
PANDEMIC;
PASSIVE IMMUNIZATION;
REGISTER;
SEVERE ACUTE RESPIRATORY SYNDROME;
STEM CELL TRANSPLANTATION;
TIME FACTOR;
TREATMENT OUTCOME;
VIROLOGY;
VIRUS PNEUMONIA;
WORLD HEALTH ORGANIZATION;
ADENOSINE MONOPHOSPHATE;
ALANINE;
ANIMALS;
ANTI-HIV AGENTS;
BETACORONAVIRUS;
CHINA;
CHLOROQUINE;
CLINICAL TRIALS AS TOPIC;
CORONAVIRUS INFECTIONS;
DIOXANES;
DISEASE MODELS, ANIMAL;
DRUG COMBINATIONS;
HUMANS;
IMMUNIZATION, PASSIVE;
LOPINAVIR;
MEDICINE, CHINESE TRADITIONAL;
MONOSACCHARIDES;
PANDEMICS;
PNEUMONIA, VIRAL;
REGISTRIES;
RITONAVIR;
SEVERE ACUTE RESPIRATORY SYNDROME;
STEM CELL TRANSPLANTATION;
STEROIDS;
TIME FACTORS;
TREATMENT OUTCOME;
WORLD HEALTH ORGANIZATION;
|
|
EID: 85079612991
PISSN: None
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/d41586-020-00444-3 Document Type: Note |
|
Times cited : (107)
|
|
References (0)
|